Summary & Overview
HCPCS Level II C1782: Morcellator, Surgical Instrument
HCPCS Level II code C1782 designates a morcellator, a surgical instrument used to fragment and remove large tissue masses during minimally invasive procedures such as laparoscopic or hysteroscopic tissue extraction. As a device-specific HCPCS Level II code, C1782 is relevant for facilities and suppliers managing device billing and for payers that adjudicate claims for operative supplies nationally. The code matters because morcellators can be associated with procedure-level supply charges and may influence billing at the facility level for minimally invasive gynecologic and general surgical procedures.
Key payers in the national landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context and typical sites of service, payer coverage considerations, and common modifier usage where applicable. The publication outlines benchmarking elements and policy considerations relevant to device billing, plus clinical context that affects utilization and coding practices. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code C1782 represents a morcellator, a surgical instrument used to fragment and remove large tissue masses during minimally invasive procedures. The service type for C1782 is surgical instrument supply, and the typical site of service is operating room or ambulatory surgery center where laparoscopic or hysteroscopic tissue extraction is performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 45–60-year-old woman presenting with symptomatic uterine fibroids causing heavy menstrual bleeding, bulk symptoms, or failed medical therapy. After evaluation with pelvic ultrasound or MRI confirming intramural or submucosal fibroids, the patient is scheduled for a minimally invasive gynecologic procedure such as laparoscopic or hysteroscopic myomectomy or hysterectomy. In the operating room or ambulatory surgery center, the surgical team uses a C1782 morcellator to fragment larger uterine tissue specimens for removal through trocar sites or transvaginally when specimen size prevents intact extraction. The workflow includes preoperative consent addressing instrument use, general anesthesia, laparoscopic or hysteroscopic access, tissue morcellation with the C1782 device, retrieval of fragments, hemostasis, and routine postoperative recovery and discharge. Documentation typically includes indication, imaging findings, informed consent for morcellation if applicable, intraoperative findings, device use (C1782 morcellator), estimated blood loss, specimens removed, and any intraoperative complications.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |